JACIJClub
Developments in mast cell research.
Journal of Allergy and Clinical Immunology · · Review · Open access
Piliponsky, Hallstrand
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
High-resolution structural and single-cell/spatial studies between January 2024 and December 2025 reveal mast cell heterogeneity and new FcεRI and MRGPRX2 signaling roles across brain, mucosa, and cancer.
- Why it matters: Mast cell biology has been incompletely understood, limiting progress on context-dependent functions in allergy, anaphylaxis, pain, infection, and tumor immunity and on more selective therapies.
- What they did: The review synthesizes advances in FcεRI structural signaling, inflammasome component function, and IgE-independent activation via MRGPRX2, alongside single-cell transcriptomics and spatial profiling.
- The result: It links these mechanistic and profiling insights to therapeutic momentum, including KIT–stem cell factor–axis antibodies, next-generation anti-IgE, Bruton tyrosine kinase inhibitors, and type 2 pathway targeting.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- Open access
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.